טוען...
Heparin in malignant glioma: review of preclinical studies and clinical results
Glioblastoma multiforme (GBM) is the most common primary brain tumor that is invariably lethal. Novel treatments are desperately needed. In various cancers, heparin and its low molecular weight derivatives (LMWHs), commonly used for the prevention and treatment of thrombosis, have shown therapeutic...
שמור ב:
| הוצא לאור ב: | J Neurooncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582077/ https://ncbi.nlm.nih.gov/pubmed/26123362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1826-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|